CHPA applauds FDA for issuing a recent order in support of the full and complete switch from prescription to nonprescription status for the laxative active ingredient polyethylene glycol (PEG) 3350.
CHPA thanks Governor Walker for signing this important bill into law as well as Senator Stroebel and Representative Kremer for their leadership and commitment to passing legislation aimed at addressing the issue of teen OTC cough medicine abuse
CHPA released the following statement today by President and CEO, Scott Melville, applauding the introduction of The Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
The 2017 results from the National Institute on Drug Abuse and University of Michigan’s annual drug abuse survey were released today showing that the percentage of teens using OTC cough medicine containing DXM to get high remains at just three percent, the lowest level recorded since 2015.
Today, CHPA announced a new initiative to support retailers in states that have adopted laws prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan to minors. The announcement comes on the heels of Nevada’s enactment of a DXM age-restriction law last week.
To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Oregon Governor Kate Brown today signed legislation prohibiting the sale of DXM-containing products to minors.
This week, Nevada Governor Brian Sandoval signed legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.
A newly published article in the medical journal Pediatrics concludes that over-the-counter (OTC) cough and cold medicines for children are safe when used and stored as directed.
“The results of this year’s Monitoring the Future survey demonstrate that prevention through education works,” Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville said.
